In a breast cancer study, EVs were engineered to express the urokinase plasminogen activator receptor for improved tumour targeting and were used as nanocarriers for miRNAs (antisense-miRNA-21 or antisense-miRNA-10b) in tumour-bearing nude mice. This evidence concerns the gene PLAUR and neoplasm.